Page last updated: 2024-12-10

genistin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

genistin: glycoside of soy bean isoflavone, gentistein [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5284639
CHEMBL ID1364260
CHEBI ID91655
SCHEMBL ID12464298
MeSH IDM0120926
PubMed CID5281377
CHEMBL ID486625
CHEBI ID27514
SCHEMBL ID62148
MeSH IDM0120926

Synonyms (97)

Synonym
AC-6045
BRD-A36151937-001-01-2
nsc5112
nsc-5112
isoflavone,5,7-trihydroxy-, 7-d-glucoside
genistein-7-glucoside
4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-
genistein, 7-.beta.-d-glucopyranoside
genistein 7-o-.beta.-d-glucoside
genistein 7-glucoside
genisteol 7-monoglucoside
genistein glucoside
NCI60_004232
smr000232340
MLS000563446
genistein, 7-o-beta-d-glucoside
genistein, 7-beta-d-glucopyranoside
isoflavone, 4',5,7-trihydroxy-, 7-d-glucoside
glucopyranoside, genistein-7, .beta.-d-
5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl hexopyranoside
5-hydroxy-3-(4-hydroxyphenyl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
HSCI1_000131
7-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3-(4-hydroxyphenyl)-5-oxidanyl-chromen-4-one
A829327
5-hydroxy-3-(4-hydroxyphenyl)-7-[[3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-1-benzopyran-4-one
HMS2219H07
glucosyl-7-genistein
AKOS015963363
FT-0626644
HMS3345H09
SCHEMBL12464298
CHEMBL1364260
genistein-7-o-beta-d-glucopyranoside
4',5,7-trihydroxyisoflavone 7-glucoside
sr-01000721801
SR-01000721801-3
CHEBI:91655
genistein-7beta-d-glucopyranoside
genistin (8ci)
Q27163479
DTXSID00859459
5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl hexopyranoside
BIDD:ER0520
genistin
genistoside
CHEBI:27514 ,
5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl beta-d-glucopyranoside
4',5,7-trihydroxyisoflavone 7-d-glucoside
genistine
nsc 5112
4h-1-benzopyran-4-one, 7-(beta-d-glucopyranosyloxy)-5-hydroxy-3-(4-hydroxyphenyl)-
glucopyranoside, genistein-7, beta-d-
brn 0064479
MEGXP0_000436
NCGC00180447-01
C09126
genistein 7-o-beta-d-glucoside
genistin, from glycine max (soybean), >=95% (hplc)
ACON1_001495
NCGC00163559-01
genistin, >=97.5% (tlc)
BRD-K51391729-001-01-4
CHEMBL486625
NCGC00163559-02
5-hydroxy-3-(4-hydroxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
1pog3scn5t ,
4-18-00-02732 (beilstein handbook reference)
unii-1pog3scn5t
5,4'-di-hydroxyisoflavone-7-o-.beta.-d-glucopyranoside
genistein genistin [mi]
4',5,7-trihydroxyisoflavone 7-.beta.-d-glucopyranoside
genistin [usp-rs]
genistein 7-o-.beta.-d-glucopyranoside
genistin (constituent of soy isoflavones) [dsc]
CCG-208377
SCHEMBL62148
smr003929926
MLS006010735
CS-4240
AKOS025146960
Q-100603
7-o-.beta.-d-glucopyranosyl genistein
HY-N0595
mfcd00016883
DTXSID3022324
genistin, analytical standard
genistein 7-o-b-d-glucopyranoside
bdbm50025609
genistin, primary pharmaceutical reference standard
genistin, united states pharmacopeia (usp) reference standard
5-hydroxy-3-(4-hydroxyphenyl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
5-hydroxy-3-(4-hydroxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
Q5533221
genistin - cas 529-59-9
genistin,(s)
AS-11684
G0358

Research Excerpts

Overview

Genistin is a glycoside form of GT (genistein-7-O-beta-D-glucopyranoside, GT-glu) It is mainly found in soy-derived foods.

ExcerptReferenceRelevance
"Genistin is a type of isoflavone glycoside and has a broad range of health benefits. "( The potential health benefits of the isoflavone glycoside genistin.
Akanda, MR; Hasan, MMI; Islam, A; Islam, MS; Uddin, MN, 2020
)
2.25
"Genistin is a glycoside form of GT (genistein-7-O-beta-D-glucopyranoside, GT-glu) is mainly found in soy-derived foods."( Comparison of oral bioavailability of genistein and genistin in rats.
Choi, YW; Ha, KW; Han, IH; Huh, JS; Kang, MJ; Kwon, SH; Lee, BS; Lee, J; Lee, JR; Lee, MS; Lee, MW; Lee, SK, 2007
)
1.31

Effects

ExcerptReferenceRelevance
"Genistin has been described to have several beneficial health impacts, such as decreasing the risk of osteoporosis and post-menopausal symptoms, as well as anti-cancer, anti-oxidative, cardioprotective, anti-apoptotic, neuroprotective, hepatoprotective, and anti-microbial activities."( The potential health benefits of the isoflavone glycoside genistin.
Akanda, MR; Hasan, MMI; Islam, A; Islam, MS; Uddin, MN, 2020
)
1.52

Actions

ExcerptReferenceRelevance
"Genistin and genistein suppress adipocyte-specific proteins and genes, such as peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding protein α (C/EBPα), and adipocyte binding protein 2 (aP2)/fatty acid-binding protein 4 (FABP4), and lipogenic enzymes such as ATP citrate lyase (ACL), acetyl-CoA carboxylase 1 (ACC1), and fatty acid synthase (FAS)."( Genistin: A Novel Potent Anti-Adipogenic and Anti-Lipogenic Agent.
Choi, YR; Kim, MJ; Shim, J, 2020
)
2.72

Compound-Compound Interactions

ExcerptReferenceRelevance
"The crude methanol extract of Pueraria lobata was investigated by dual high-resolution α-glucosidase inhibition and radical scavenging profiling combined with hyphenated HPLC-HRMS-SPE-NMR."( Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
Jäger, AK; Kongstad, KT; Liu, B; Nyberg, NT; Qinglei, S; Staerk, D, 2015
)
0.42

Bioavailability

In previous experiments, genistin absorption rate of 17.5% was achieved.

ExcerptReferenceRelevance
"05) absorption rate during small intestinal passage."( Isoflavones from tofu are absorbed and metabolized in the isolated rat small intestine.
Andlauer, W; Fürst, P; Kolb, J, 2000
)
0.31
", genistein) were comparable to well absorbed compounds, such as testosterone and propranolol."( Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.
Hu, M; Liu, Y, 2002
)
0.31
" Controversy exists regarding the extent of bioavailability of isoflavone glycosides, and the mechanism of intestinal absorption of isoflavones in humans is unclear."( Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability.
Brashear, WT; Brown, NM; Heubi, JE; Kirschner, AS; Setchell, KD; Wolfe, BE; Zimmer-Nechemias, L, 2002
)
0.31
" Bioavailability of isoflavones was confirmed by gas chromatography-mass spectrometry analysis."( Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability.
Brashear, WT; Brown, NM; Heubi, JE; Kirschner, AS; Setchell, KD; Wolfe, BE; Zimmer-Nechemias, L, 2002
)
0.31
"Isoflavone glycosides are not absorbed intact across the enterocyte of healthy adults, and their bioavailability requires initial hydrolysis of the sugar moiety by intestinal beta-glucosidases for uptake to the peripheral circulation."( Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability.
Brashear, WT; Brown, NM; Heubi, JE; Kirschner, AS; Setchell, KD; Wolfe, BE; Zimmer-Nechemias, L, 2002
)
0.31
" High intakes and an adequate absorption rate of isoflavones are necessary for efficient chemoprevention, though other dietary agents might increase absorption efficacy."( Phloridzin improves absorption of genistin in isolated rat small intestine.
Andlauer, W; Fürst, P; Kolb, J, 2004
)
0.6
"In previous experiments, genistin absorption rate of 17."( Phloridzin improves absorption of genistin in isolated rat small intestine.
Andlauer, W; Fürst, P; Kolb, J, 2004
)
0.91
"The present study describes an in vivo bioavailability experiment for genistein and its glycoside genistin, either as pure compounds or from a soy protein isolate extract, using freely moving unanesthetized rats with a cannulation in the portal vein."( Bioavailability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats.
Faassen-Peters, MA; Noteborn, HP; Rietjens, IM; Steensma, A, 2006
)
0.81
" In this study, we examined the pharmacokinetic properties and bioavailability of GT in rats and compared with those of GT-glu."( Comparison of oral bioavailability of genistein and genistin in rats.
Choi, YW; Ha, KW; Han, IH; Huh, JS; Kang, MJ; Kwon, SH; Lee, BS; Lee, J; Lee, JR; Lee, MS; Lee, MW; Lee, SK, 2007
)
0.59
" Because of their bioactivity, isoflavone bioavailability has been extensively studied in humans."( Review of the factors affecting bioavailability of soy isoflavones in humans.
Nielsen, IL; Williamson, G, 2007
)
0.34
" The intestinal microflora is important in rendering soy isoflavones bioavailability by facilitating their conversion to equol."( Combination of genistin and fructooligosaccharides prevents bone loss in ovarian hormone deficiency.
Arjmandi, BH; Hooshmand, S; Juma, S, 2010
)
0.71
" However, these studies cannot reflect the realistic effects that soy may induce through diets, and little is known about the bioavailability of isoflavones from whole soy food and their bioactivities after cooking and digestion."( Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
Dong, X; Sikes, RA; Wu, C; Xu, W, 2012
)
0.38
"Despite considerable interest in the physiologic effects of isoflavones, the in vivo bioavailability of the most common isoflavone forms, malonylglucoside conjugates, has not been determined."( Malonylglucoside conjugates of isoflavones are much less bioavailable compared with unconjugated β-glucosidic forms in rats.
Gallaher, DD; Ismail, B; Yerramsetty, V, 2014
)
0.4
" The aim of this study was to investigate the effect of a fixed combination of soy isoflavones on the oral bioavailability of levothyroxine in post-menopausal female volunteers."( Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.
Barbetta, B; Benvenuti, C; Colovic, M; Donazzolo, Y; Giacovelli, G; Manzotti, C; Persiani, S; Rovati, LC; Sala, F; Vitalini, C; Zangarini, M, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" These models have used various dosing strategies to mimic the phytoestrogen levels in human populations."( Circulating levels of genistein in the neonate, apart from dose and route, predict future adverse female reproductive outcomes.
Jefferson, WN; Williams, CJ, 2011
)
0.37
" The model obtained was used to translate in vitro oestrogenic concentration-response curves of genistein to in vivo oestrogenic dose-response curves for intake of genistein and genistin."( In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.
Boonpawa, R; Punt, A; Rietjens, IMCM; Spenkelink, A, 2017
)
0.65
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
acrovestoneA polyphenol that is isolated from Acronychia pedunculata and exhibits moderate antioxidant and antityrosinase activities.
isoflavonoidAny 1-benzopyran with an aryl substituent at position 3. The term was originally restricted to natural products, but is now also used to describe semi-synthetic and fully synthetic compounds.
7-hydroxyisoflavones 7-O-beta-D-glucosideA glycosyloxyisoflavone that is any 7-hydroxyisoflavone compound in which the 7-hydroxy group has been converted into its corresponding O-beta-D-glucoside.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
genistein conjugates interconversion017
genistin gentiobioside biosynthesis16

Protein Targets (20)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency79.43280.044717.8581100.0000AID485294
Chain A, Ferritin light chainEquus caballus (horse)Potency50.11875.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency23.93410.007215.758889.3584AID588342
BRCA1Homo sapiens (human)Potency8.91250.89137.722525.1189AID624202
ATAD5 protein, partialHomo sapiens (human)Potency11.89050.004110.890331.5287AID504466; AID504467
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency0.63100.707936.904389.1251AID504333
P53Homo sapiens (human)Potency11.22020.07319.685831.6228AID504706
IDH1Homo sapiens (human)Potency29.09290.005210.865235.4813AID686970
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency5.62340.01262.451825.0177AID485313
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency39.81070.001815.663839.8107AID894
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency29.09290.00419.984825.9290AID504444
ras-related protein Rab-9AHomo sapiens (human)Potency5.62340.00022.621531.4954AID485297
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency4.46680.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency4.46680.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency4.46680.15855.287912.5893AID540303
gemininHomo sapiens (human)Potency29.09290.004611.374133.4983AID624297
survival motor neuron protein isoform dHomo sapiens (human)Potency25.11890.125912.234435.4813AID1458
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency0.39810.00419.962528.1838AID2675
lamin isoform A-delta10Homo sapiens (human)Potency31.62280.891312.067628.1838AID1487
TAR DNA-binding protein 43Homo sapiens (human)Potency0.28181.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (63)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1850986Displacement of thiazole orange from human ILPR i-motif DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID643985Estrogenic activity in ER expressing human Ishikawa cells assessed as induction of ALP activity at 1 pM to 1 uM in presence of 17beta-E22012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1850974Binding affinity to human ILPR G4 quadruplex DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1428453Antibacterial activity against Escherichia coli DH10B by EUCAST method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1850989Displacement of thiazole orange from human ILPR i-motif DNA at 100 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850980Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1428452Antifungal activity against Cryptococcus neoformans H99 by CLSI M27-A3 broth microdilution method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID1850985Displacement of thiazole orange from human ILPR G4 quadruplex DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1082304Insecticidal activity against fourth instar larval stage of Spodoptera litura in glandless fresh cabbage leaves assessed as growth inhibition measured 3 days after feeding diet containing compound2011Journal of agricultural and food chemistry, Jun-08, Volume: 59, Issue:11
Secondary metabolites from Glycine soja and their growth inhibitory effect against Spodoptera litura.
AID1850983Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 100 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850991Displacement of thiazole orange from human 1BNA double stranded DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID1204996Inhibition of Saccharomyces cerevisiae alpha-glucosidase type 1 assessed as 4-nitrophenol cleavage product by high-resolution biochromatogram2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID643984Osteogenic activity in rat primary calvarial osteoblasts assessed as induction of ALP activity at 1 pM to 1 uM after 10 days by colorimetry in presence of anti-estrogen ICI-1827802012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID358171Inhibition of EGFR in human A431 cells1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID456319ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID1850972Binding affinity to human telomeric 1ELN i-motif DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1850971Binding affinity to human telomeric IKF1 G4 quadruplex DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID643057Induction of rat calvarial osteoblast mineralization assessed as increase in formation of mineralized calcium nodules at 100 pM after 21 days by alizarin red-S staining-based assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1850984Displacement of thiazole orange from human ILPR G4 quadruplex DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1082303Drug metabolism in fourth instar larval stage of Spodoptera litura assessed in excrements after feeding diet containing compound by HPLC analysis2011Journal of agricultural and food chemistry, Jun-08, Volume: 59, Issue:11
Secondary metabolites from Glycine soja and their growth inhibitory effect against Spodoptera litura.
AID1180340Antioxidant activity assessed as AAPH-induced peroxyl radical scavenging activity at 10 uM by oxygen radical absorbance assay relative to trolox2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID1428454Antibacterial activity against Staphylococcus aureus NCTC 8325-4 by EUCAST method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID1180339Antioxidant activity assessed as AAPH-induced peroxyl radical scavenging activity by oxygen radical absorbance assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID1428451Antifungal activity against Candida albicans SC5314 by CLSI M27-A3 broth microdilution method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID1850979Displacement of thiazole orange from human telomeric IKF1 G4 quadruplex DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850981Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850987Displacement of thiazole orange from human ILPR i-motif DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID643054Toxicity in rat calvarial osteoblast cells at 1 pM to 1 uM after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1355607Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells pretreated for 1 hr followed by LPS-stimulation and measured after 24 hrs by Griess assay2018Journal of natural products, 07-27, Volume: 81, Issue:7
Chemical Constituents of Apios americana Tubers and Their Inhibitory Activities on Nitric Oxide Production in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages.
AID1204997Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
AID643972Osteogenic activity in rat primary calvarial osteoblasts assessed as induction of ALP activity at 1 pM to 1 uM after 10 days by colorimetry2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1850990Displacement of thiazole orange from human 1BNA double stranded DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID643983Antiestrogenic activity in ER expressing human Ishikawa cells assessed as inhibition of ALP activity at 1 pM to 1 uM2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1850973Binding affinity to human telomeric 1ELN i-motif DNA assessed as change in melting temperature at 20 uM at pH 5.5 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850977Binding affinity to human 1BNA double stranded DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1082305Antifeedant activity against fourth instar larval stage of Spodoptera litura on fresh cabbage leaves2011Journal of agricultural and food chemistry, Jun-08, Volume: 59, Issue:11
Secondary metabolites from Glycine soja and their growth inhibitory effect against Spodoptera litura.
AID1850988Displacement of thiazole orange from human ILPR i-motif DNA at 10 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1428455Renoprotective activity in pig LLC-PK1 cells assessed as inhibition of cisplatin-induced damage by measuring cell viability up to 100 uM preincubated for 24 hrs followed by addition of Ez-Cytox reagent and measured after 2 hrs relative to control2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID1850982Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 10 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850978Displacement of thiazole orange from human telomeric IKF1 G4 quadruplex DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850976Binding affinity to human ILPR i-motif DNA assessed as change in melting temperature at 20 uM at pH 5.5 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID643980Estrogenic activity in ER expressing human Ishikawa cells assessed as induction of ALP activity at 1 pM to 1 uM2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1850975Binding affinity to human ILPR i-motif DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (195)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (2.05)18.7374
1990's22 (11.28)18.2507
2000's73 (37.44)29.6817
2010's77 (39.49)24.3611
2020's19 (9.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.55 (24.57)
Research Supply Index5.35 (2.92)
Research Growth Index5.39 (4.65)
Search Engine Demand Index79.51 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (36.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials8 (3.98%)5.53%
Reviews0 (0.00%)6.00%
Reviews6 (2.99%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
Other187 (93.03%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]